Leaflet MYDERISON 150mg film-coated tablets


Indicated for: spasticity; muscle spasms

Route of administration: oral

Substance: tolperisone (muscle relaxant)

ATC: M03BX04 (Musculo-skeletal system | Muscle relaxants, centrally acting agents | Other centrally acting agents)

Tolperisone is a medication used to treat muscle spasms and muscle hypertonicity associated with neurological or musculoskeletal conditions, such as multiple sclerosis, strokes, spinal cord injuries, or back pain. It is a centrally acting muscle relaxant that reduces excessive muscle tone without causing significant sedation.

Tolperisone works by inhibiting the transmission of nerve impulses in the spinal cord and improving local blood circulation, which helps reduce muscle spasms and associated pain. The medication is taken orally, usually 2-3 times per day, as directed by a doctor.

Common side effects include nausea, vomiting, abdominal pain, dizziness, and allergic reactions such as skin rashes or itching. In rare cases, severe hypersensitivity reactions may occur. Tolperisone is contraindicated in patients with myasthenia gravis (a neuromuscular disease) and should be used with caution in pregnant or breastfeeding women.

General data about MYDERISON 150mg

  • Substance: tolperisone
  • Date of last drug list: 01-04-2022
  • Commercial code: W68584001
  • Concentration: 150mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 20
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: MEDITOP PHARMACEUTICAL LTD - UNGARIA
  • Holder: MEDITOP PHARMACEUTICAL LTD. - UNGARIA
  • Number: 11571/2019/01
  • Shelf life: 5 years

Pharmaceutical forms available for tolperisone

Concentrations available for tolperisone

  • 100mg/ml
  • 150mg
  • 50mg